These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16636894

  • 1. Prognostic impact of Skp2 and p27 in human breast cancer.
    Traub F, Mengel M, Lück HJ, Kreipe HH, von Wasielewski R.
    Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894
    [Abstract] [Full Text] [Related]

  • 2. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D, Nielsen TO, Cheang MC, Foulkes WD.
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [Abstract] [Full Text] [Related]

  • 4. Significance of skp2 expression in primary breast cancer.
    Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1215-20. PubMed ID: 16489076
    [Abstract] [Full Text] [Related]

  • 5. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
    Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, Nakayama K, Nakayama K, Mori M.
    Cancer Res; 2002 Jul 01; 62(13):3819-25. PubMed ID: 12097295
    [Abstract] [Full Text] [Related]

  • 6. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A, Yoshino I, Tanaka S, Sugio K, Kameyama T, Yamaguchi M, Maehara Y.
    J Clin Oncol; 2004 Oct 15; 22(20):4165-73. PubMed ID: 15483027
    [Abstract] [Full Text] [Related]

  • 7. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
    Langner C, von Wasielewski R, Ratschek M, Rehak P, Zigeuner R.
    Urology; 2004 Sep 15; 64(3):611-6. PubMed ID: 15351619
    [Abstract] [Full Text] [Related]

  • 8. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications.
    Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M.
    Oncol Rep; 2003 Sep 15; 10(2):321-5. PubMed ID: 12579266
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M.
    Oncol Rep; 2006 Apr 15; 15(4):765-71. PubMed ID: 16525656
    [Abstract] [Full Text] [Related]

  • 10. Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma.
    Masuda TA, Inoue H, Nishida K, Sonoda H, Yoshikawa Y, Kakeji Y, Utsunomiya T, Mori M.
    Clin Cancer Res; 2003 Nov 15; 9(15):5693-8. PubMed ID: 14654553
    [Abstract] [Full Text] [Related]

  • 11. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
    Huang HY, Kang HY, Li CF, Eng HL, Chou SC, Lin CN, Hsiung CY.
    Clin Cancer Res; 2006 Jan 15; 12(2):487-98. PubMed ID: 16428491
    [Abstract] [Full Text] [Related]

  • 12. Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy.
    Zheng WQ, Zheng JM, Ma R, Meng FF, Ni CR.
    Steroids; 2005 Oct 15; 70(11):770-4. PubMed ID: 16024059
    [Abstract] [Full Text] [Related]

  • 13. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, Krek W.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):5043-8. PubMed ID: 11309491
    [Abstract] [Full Text] [Related]

  • 14. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
    Huang CW, Lin CY, Huang HY, Liu HW, Chen YJ, Shih DF, Chen HY, Juan CC, Ker CG, Huang CY, Li CF, Shiue YL.
    Ann Surg Oncol; 2010 Mar 24; 17(3):907-22. PubMed ID: 19866239
    [Abstract] [Full Text] [Related]

  • 15. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY, Ding W, Xie LP, Chen ZD.
    Ai Zheng; 2004 Feb 24; 23(2):215-8. PubMed ID: 14960249
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
    Goto A, Niki T, Moriyama S, Funata N, Moriyama H, Nishimura Y, Tsuchida R, Kato JY, Fukayama M.
    Pathol Int; 2004 Sep 24; 54(9):675-81. PubMed ID: 15363035
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
    Chiappetta G, De Marco C, Quintiero A, Califano D, Gherardi S, Malanga D, Scrima M, Montero-Conde C, Cito L, Monaco M, Motti ML, Pasquinelli R, Agosti V, Robledo M, Fusco A, Viglietto G.
    Endocr Relat Cancer; 2007 Jun 24; 14(2):405-20. PubMed ID: 17639054
    [Abstract] [Full Text] [Related]

  • 18. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
    Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T.
    Cancer Res; 2001 Oct 01; 61(19):7044-7. PubMed ID: 11585732
    [Abstract] [Full Text] [Related]

  • 19. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.
    Li Q, Murphy M, Ross J, Sheehan C, Carlson JA.
    J Cutan Pathol; 2004 Nov 01; 31(10):633-42. PubMed ID: 15491322
    [Abstract] [Full Text] [Related]

  • 20. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S, Ahmed M, Bavi P, El-Sayed R, Al-Sanea N, AbdulJabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Hussain AR, Al-Kuraya KS.
    Cancer Res; 2008 May 01; 68(9):3379-88. PubMed ID: 18451165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.